French-based biotech giant Aventis is due to tell a US Environmental Protection Agency panel this week that trace amounts of its much-maligned GM corn StarLink corn pose no threat to the US food supply.
StarLink, which had been sold in the US for three years, was pulled from the market over fears that it could cause an allergic reaction in human consumers. The corn was approved for use in livestock feed, but Aventis agreed to buy the 2000 crop back from farmers after mass recalls when food products became contaminated.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The EPA panel ruled in December that there existed a “low probability” that trace amounts of the corn would cause an allergic reaction. Nevertheless it found that there is a “medium likelihood” that allergic reactions would be sparked by the corn, and that children were more likely to experience reactions.
In a bid to prevent the upheaval of further product recalls due to trace elements of StarLink, Aventis is to tell the EPA that minute amounts of the corn do not pose a threat to consumers’ health.
To view related research reports, please follow the links below:- World Agricultural Biotechnology: GMOs to 2004 
GlobalData Strategic Intelligence
US Tariffs are shifting - will you react or anticipate?Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis. By GlobalDataHandbook on the Labelling of Genetically Modified Foods, Ingredients and Additives |
